Prokinetic therapy for feed intolerance in critical illness: One drug or two?

Critical Care Medicine

Volumn 35, Issue 11, 2007, Pages 2561-2567

  Nguyen, Nam Q ^a,c   Chapman, Marianne ^a   Fraser, Robert J ^a,b   Bryant, Laura K ^b   Burgstad, Carly ^a   Holloway, Richard H ^a  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b REPATRIATION GENERAL HOSPITAL   (Australia)

^c ROYAL ADELAIDE HOSPITAL   (Australia)

Author keywords

Critical illness; Enteral feeding; Erythromycin; Metoclopramide; Nutrition; Prokinetic

Indexed keywords

BENZODIAZEPINE; ERYTHROMYCIN; METOCLOPRAMIDE; OPIATE; ANTIEMETIC AGENT; GASTROINTESTINAL AGENT;

ADULT; ARTICLE; ARTIFICIAL VENTILATION; CALORIC INTAKE; CLINICAL TRIAL; COMBINATION CHEMOTHERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; DEMOGRAPHY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; FEMALE; GASTRIC SUCTION; HUMAN; HYPOALBUMINEMIA; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MONOTHERAPY; MORTALITY; NUTRITIONAL INTOLERANCE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEDATION; STOMACH VOLUME; TACHYPHYLAXIS; TREATMENT OUTCOME; TREATMENT RESPONSE; VERNER MORRISON SYNDROME; VOMITING; COMPARATIVE STUDY; DRUG COMBINATION; ENTERIC FEEDING; MIDDLE AGED; PROSPECTIVE STUDY;

ANTIEMETICS; CRITICAL ILLNESS; DOUBLE-BLIND METHOD; DRUG THERAPY, COMBINATION; ENTERAL NUTRITION; ERYTHROMYCIN; FEMALE; GASTROINTESTINAL AGENTS; HUMANS; MALE; METOCLOPRAMIDE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 37549049069     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000286397.04815.B1     Document Type: Article

References (42)

1. De Beaux M Chapman R Fraser Enteral nutrition in the critically ill: A prospective survey in an Australian intensive care unit Anaesth Intensive Care 29 2001 619 622
2. A Dive M Moulart P Jonard Gastroduodenal motility in mechanically ventilated critically ill patients: A manometric study Crit Care Med 22 1994 441 447
3. G Multu E Multu P Factor Gastrointestinal complications in patients receiving mechanical ventilation Chest 119 2001 1222 1241
4. DK Heyland R Dhaliwal JW Drover Canadian Critical Care Clinical Practice Guidelines C: Canadian clinical practice guidelines for nutrition support in mechanically ventilated, critically ill adult patients JPEN J Parenter Enteral Nutr 27 2003 355 373
5. D Heyland DJ Cook B Winder Enteral nutrition in the critically ill patient: A prospective survey Crit Care Med 23 1995 1055 1060
6. DT Dempsey JL Mullen GP Buzby The link between nutritional status and clinical outcome: Can nutritional intervention modify it? Am J Clin Nutr 47 1988 352 356
7. DK Heyland G Tougas D King Impaired gastric emptying in mechanically ventilated, critically ill patients Intensive Care Med 22 1996 1339 1344
8. HC Sax WW Souba Enteral and parenteral feedings. Guidelines and recommendations Med Clin North Am 77 1993 863 880
9. MH Shuster Enteral feeding of the critically ill AACN Clin Issues Crit Care Nurs 5 1994 459 475
10. M Stroud H Duncan J Nightingale Guidelines for enteral feeding in adult hospital patients Gut 52 2003 vii1 vii12
11. SA Tisherman PE Marik J Ochoa Promoting enteral feeding 101 Crit Care Med 30 2002 1653 1654
12. R MacLaren Intolerance to intragastric enteral nutrition in critically ill patients: Complications and management Pharmacotherapy 20 2000 1486 1498
13. C Jooste J Mustoe G Collee Metoclopramide improves gastric motility in critically ill patients Intensive Care Med 25 1999 464 468
14. R MacLaren W Patrick R Hall Comparison of cisapride and metoclopramide for facilitating gastric emptying and improving tolerance to intragastric enteral nutrition in critically III, mechanically ventilated adults Clin Ther 23 2001 1855 1866
15. R MacLaren D Kuhl J Gervasio Sequential single doses of cisapride, erythromycin, and metoclopramide in critically ill patients intolerant to enteral nutrition: A randomized, placebo-controlled, crossover study Crit Care Med 28 2000 438 444
16. M Chapman R Fraser M Kluger Erythromycin improves gastric emptying in critically ill patients intolerant of nasogastric feeding Crit Care Med 28 2000 2334 2337
17. A Dive C Miesse L Galanti Effect of erythromycin on gastric motility in mechanically ventilated critically ill patients: A double-blind, randomized, placebo-controlled study Crit Care Med 23 1995 1356 1362
18. J Reignier S Bensaid D Perrin-Gachadoat Erythromycin and early enteral nutrition in mechanically ventilated patients Crit Care Med 30 2002 1237 1241
19. J Berne S Norwood C McAuley Erythromycin reduces delayed gastric emptying in critically ill trauma patients: A randomized, controlled trial J Trauma 53 2002 422 425
20. NQ Nguyen M Chapman R Fraser Erythromycin is more effective than metoclopramide for treatment of feed intolerance in critical illness Crit Care Med 35 2007 483 489
21. TW Kelly MR Patrick KM Hillman Study of diarrhea in critically ill patients Crit Care Med 11 1983 7 9
22. CP Kelly C Pothoulakis JT LaMont Clostridium difficile colitis N Engl J Med 330 1994 257 262
23. SA McClave HL Snider CC Lowen Use of residual volume as a marker for enteral feeding intolerance: Prospective blinded comparison with physical examination and radiographic findings JPEN J Parenter Enteral Nutr 16 1992 99 105
24. SA McClave JK Lukan JA Stefater Poor validity of residual volumes as a marker for risk of aspiration in critically ill patients Crit Care Med 33 2005 324 330
25. S McClave D DeMeo M DeLegge North American Summit on Aspiration in the Critically Ill Patient: Consensus statement JPEN J Parenter Enteral Nutr 26 2002 S80 S85
26. HC Lin JE Doty TJ Reedy Inhibition of gastric emptying by glucose depends on length of intestine exposed to nutrient Am J Physiol 256 1989 G404 G411
27. GJ Sanger FD King From metoclopramide to selective gut motility stimulants and 5-HT3 receptor antagonists Drug Design Deliv 3 1988 273 295
28. K Buchheit B Costall G Engel 5-Hydroxytryptamine receptor antagonism by metoclopramide and ICS 205–930 in the guinea-pig leads to enhancement of contractions of stomach muscle strips induced by electrical field stimulation and facilitation of gastric emptying in vivo J Pharm Pharmacol 37 1985 664 667
29. J Curry T Lander M Stringer Review article: Erythromycin as a prokinetic agent in infants and children Aliment Pharmacol Ther 15 2001 595 603
30. J Kellow M Delvaux F Azpiroz Principles of applied neurogastroenterology: Physiology/motility-sensation Gut 45 1999 II17 II24
31. T Erbas E Varoglu B Erbas Comparison of metoclopramide and erythromycin in the treatment of diabetic gastroparesis Diabetes Care 16 1993 1511 1514
32. J Janssens T Peeters G Vantrappen Improvement of gastric emptying in diabetic gastroparesis by erythromycin: Preliminary studies N Engl J Med 322 1990 1028 1031
33. L Thielemans I Depoortere J Perret Desensitization of the human motilin receptor by motilides J Pharmacol Exp Ther 313 2005 1397 1405
34. V Lamian A Rich Z Ma Characterization of agonist-induced motilin receptor trafficking and its implications for tachyphylaxis Mol Pharmacol 69 2006 109 118
35. S Kannan Molecular basis of the evolution of drug resistance: potential role of the transient state during infection/drug treatment Med Hypotheses 63 2004 71 72
36. N Komarova D Wodarz Drug resistance in cancer: principles of emergence and prevention Proc Natl Acad Sci U S A 102 2005 9714 9719
37. J Guerin F Leibinger Why not to use erythromycin in GI motility Chest 121 2002 301
38. M Tonini F De Ponti A Di Nucci Review article: Adverse effects of gastrointestinal prokinetics Aliment Pharmacol Ther 13 1999 1581 1591
39. A Walker P Szneke L Weatherby The risk of serious cardiac arrhythmias among cisapride users in the United Kingdom and Canada Am J Med 107 1999 356 362
40. N Talley M Verlinden D Geenen Effects of motilin receptor agonist (ABT-229) on upper gastrointestinal symptoms in type 1 diabetes mellitus: A randomised, double blind, placebo controlled trial Gut 49 2001 395 401
41. E Castillo S Delgado-Aros M Camilleri Effect of oral CCK-1 agonist GI181771X on fasting and postprandial gastric functions in healthy volunteers Am J Physiol 287 2004 G363 G369
42. F Cremonini M Camilleri S McKinzie Effect of CCK-1 antagonist, dexloxiglumide, in female patients with irritable bowel syndrome: a pharmacodynamic and pharmacogenomic study Am J Gastroenterol 100 2005 652 663